Our findings offer insights into the mechanisms underlying pseudogene lncRNA‐associated gastric carcinoma progression and lay the foundation for further PIN1P1/PIN1‐targeting therapeutical approaches for gastric cancer. This evidence concerns the gene PIN1P1 and gastric carcinoma.